The US District Court upholds the FDA’s approval of Avadel’s Lumryz, dismissing Jazz’s challenge over market exclusivity for ...

Decentralized clinical trials are transforming medical research with more flexibility, improved patient engagement and faster ...

The European Commission (EC) has imposed a fine of €462.6m ($502m) on Teva Pharmaceuticals Industries after investigating the ...

AbbVie has entered into a partnership and option-to-license agreement with EvolveImmune Therapeutics, to develop ...

The committee was not convinced that the benefit of Zynquista outweighed the risk in adults with type 1 diabetes and chronic ...

Through a partnership, the NCCN is adapting its Harmonized Guidelines for cancer treatment for use in Vietnam.

As the Horizon acquisition reaps its benefits, Amgen is now turning eyes to its obesity and diabetes portfolio.

Reeves' budget promised investment for innovation and R&D with a view to "harnessing the full potential of the UK’s science ...

The company has axed 80% of its staff and is considering a wind-down after the out-licencing deal of its lead antifungal was ...

Green chemistry has the potential to revolutionise the pharmaceutical industry.

Experts predict that physicians may favour emerging biosimilar versions of Stelara over more effective originator IL-23 drugs ...

Biogen and Neomorph have partnered to discover and develop molecular glue degraders for treating Alzheimer’s and other rare ...